Delivery Order SPE2DB22D2206-SPE2DB25FJC75
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,198.70 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, reflecting DLA's role in supplying...
- The Defense Logistics Agency awarded a delivery order valued at $45,421.87 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s. This contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $25,167.42 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules under a firm fixed-price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 12,000 units of Creon DR 100s capsules, valued at $1,907.62, with a firm fixed price contract type. This delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a small-value transaction for pharmaceutical supplies to support federal medical procurement needs. The order was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,616.16 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement therapy commonly prescribed for patients with pancreatic insufficiency. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed from...
- The Defense Logistics Agency awarded a delivery order valued at $42,783.63 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 36,000 units of Creon DR 100s capsules. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by August 20, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $17,491.89 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of 36,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pharmaceutical enzyme replacement therapy used to treat pancreatic insufficiency and digestive disorders,...
- The Defense Logistics Agency awarded a delivery order valued at $1,860.27 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This competitive, firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.88 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement medication. The contract, which was competitively awarded with no set-aside designation, has a performance completion date of August 5, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed price arrangement and represents a child...